CLINICAL_TRIALS trial_result · 2021-09-22

Clinical Trial Update: Riluzole in Mild Alzheimer's Disease [Phase 2]

Phase 2 trial evaluating riluzole in mild Alzheimer's disease has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Alzheimer's Disease | Phase 2 | Status: COMPLETED | Results posted: 2021-09-22